lactic acid has been researched along with Disbacteriosis in 21 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We describe 2 children with SBS who we believe are the second and third patients documented to have experienced both D-lactic acidosis and urolithiasis." | 7.88 | Stoned-A Syndrome of D-Lactic Acidosis and Urolithiasis. ( Berman, CM; Merritt, RJ, 2018) |
| ", lactic acid, and 3-hydroxybutyric acid) levels have been suggested to reflect the dysbiosis of human gut microbiota, which represents an additional factor involved in the onset of heart failure (HF) disease." | 4.31 | HiSorb sorptive extraction for determining salivary short chain fatty acids and hydroxy acids in heart failure patients. ( Biagini, D; Di Francesco, F; Ghimenti, S; Lenzi, A; Lomonaco, T; Salvo, P; Vivaldi, FM, 2023) |
| " We describe 2 children with SBS who we believe are the second and third patients documented to have experienced both D-lactic acidosis and urolithiasis." | 3.88 | Stoned-A Syndrome of D-Lactic Acidosis and Urolithiasis. ( Berman, CM; Merritt, RJ, 2018) |
| "While intestinal dysbiosis has been proposed as one of the possible factors involved in NEC pathogenesis, the role of the gut microbiota remains poorly understood." | 1.62 | Unraveling the Microbiome of Necrotizing Enterocolitis: Insights in Novel Microbial and Metabolomic Biomarkers. ( Alessandri, G; Anzalone, R; Bernasconi, S; Cesare Marincola, F; De Magistris, A; Dessì, A; Fanos, V; Fontana, F; Longhi, G; Lugli, GA; Mancabelli, L; Milani, C; Mussap, M; Noto, A; Picaud, JC; Pintus, R; Tarracchini, C; Turroni, F; Ventura, M; Viappiani, A; Vincent, M, 2021) |
| "The aetiology of colic, a functional gastrointestinal disorder in infants, is not yet resolved." | 1.46 | Lactate-utilizing community is associated with gut microbiota dysbiosis in colicky infants. ( Braegger, CP; Chassard, C; Lacroix, C; Pham, VT, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 15 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Tarracchini, C | 1 |
| Milani, C | 1 |
| Longhi, G | 1 |
| Fontana, F | 1 |
| Mancabelli, L | 1 |
| Pintus, R | 1 |
| Lugli, GA | 1 |
| Alessandri, G | 1 |
| Anzalone, R | 1 |
| Viappiani, A | 1 |
| Turroni, F | 1 |
| Mussap, M | 1 |
| Dessì, A | 1 |
| Cesare Marincola, F | 1 |
| Noto, A | 1 |
| De Magistris, A | 1 |
| Vincent, M | 1 |
| Bernasconi, S | 1 |
| Picaud, JC | 1 |
| Fanos, V | 1 |
| Ventura, M | 1 |
| Chen, L | 1 |
| Li, R | 1 |
| Wang, Z | 2 |
| Zhang, Z | 1 |
| Wang, J | 2 |
| Qiao, Y | 1 |
| Huang, Y | 1 |
| Liu, W | 1 |
| Sun, S | 1 |
| Xu, X | 1 |
| Liang, L | 1 |
| Wang, X | 1 |
| Bai, X | 1 |
| Zhu, L | 1 |
| He, Q | 1 |
| Liang, H | 1 |
| Xin, X | 1 |
| Wang, L | 1 |
| Lou, C | 1 |
| Cao, X | 1 |
| Chen, X | 2 |
| Li, B | 1 |
| Wang, B | 1 |
| Zhao, J | 1 |
| Zheng, D | 1 |
| Liao, H | 1 |
| Chen, S | 1 |
| Liu, X | 1 |
| Mao, C | 1 |
| Zhang, C | 1 |
| Meng, M | 1 |
| Wang, Y | 1 |
| Jiang, Q | 1 |
| Xue, Y | 1 |
| Zhou, L | 1 |
| Chen, Y | 1 |
| Ahrodia, T | 1 |
| Yodhaanjali, JR | 1 |
| Das, B | 1 |
| Taylor, SJ | 3 |
| Winter, MG | 4 |
| Gillis, CC | 4 |
| Silva, LAD | 3 |
| Dobbins, AL | 3 |
| Muramatsu, MK | 3 |
| Jimenez, AG | 3 |
| Chanin, RB | 4 |
| Spiga, L | 4 |
| Llano, EM | 3 |
| Rojas, VK | 3 |
| Kim, J | 3 |
| Santos, RL | 4 |
| Zhu, W | 4 |
| Winter, SE | 4 |
| Seelbinder, B | 1 |
| Lohinai, Z | 1 |
| Vazquez-Uribe, R | 1 |
| Brunke, S | 1 |
| Mirhakkak, M | 1 |
| Lopez-Escalera, S | 1 |
| Dome, B | 1 |
| Megyesfalvi, Z | 1 |
| Berta, J | 1 |
| Galffy, G | 1 |
| Dulka, E | 1 |
| Wellejus, A | 1 |
| Weiss, GJ | 1 |
| Bauer, M | 1 |
| Hube, B | 1 |
| Sommer, MOA | 1 |
| Panagiotou, G | 1 |
| Lenzi, A | 1 |
| Biagini, D | 1 |
| Ghimenti, S | 1 |
| Vivaldi, FM | 1 |
| Salvo, P | 1 |
| Di Francesco, F | 1 |
| Lomonaco, T | 1 |
| Button, JE | 1 |
| Cosetta, CM | 1 |
| Reens, AL | 1 |
| Brooker, SL | 1 |
| Rowan-Nash, AD | 1 |
| Lavin, RC | 1 |
| Saur, R | 1 |
| Zheng, S | 1 |
| Autran, CA | 1 |
| Lee, ML | 1 |
| Sun, AK | 1 |
| Alousi, AM | 1 |
| Peterson, CB | 1 |
| Koh, AY | 1 |
| Rechtman, DJ | 1 |
| Jenq, RR | 1 |
| McKenzie, GJ | 1 |
| Asensio-Grau, A | 1 |
| Calvo-Lerma, J | 1 |
| Ferriz-Jordán, M | 1 |
| García-Hernández, J | 1 |
| Heredia, A | 1 |
| Andrés, A | 1 |
| Song, EJ | 1 |
| Lee, ES | 1 |
| Kim, YI | 1 |
| Shin, DU | 1 |
| Eom, JE | 1 |
| Shin, HS | 1 |
| Lee, SY | 1 |
| Nam, YD | 1 |
| Shi, Q | 1 |
| Zhou, M | 1 |
| Zheng, R | 1 |
| Zhang, X | 1 |
| Liu, B | 1 |
| Schwecht, I | 1 |
| Nazli, A | 1 |
| Gill, B | 1 |
| Kaushic, C | 1 |
| Blake, AB | 1 |
| Guard, BC | 1 |
| Honneffer, JB | 1 |
| Lidbury, JA | 1 |
| Steiner, JM | 1 |
| Suchodolski, JS | 1 |
| Ye, Z | 1 |
| Wu, C | 1 |
| Zhang, N | 1 |
| Du, L | 1 |
| Cao, Q | 1 |
| Huang, X | 1 |
| Tang, J | 1 |
| Wang, Q | 1 |
| Li, F | 1 |
| Zhou, C | 1 |
| Xu, Q | 1 |
| Xiong, X | 1 |
| Kijlstra, A | 1 |
| Qin, N | 1 |
| Yang, P | 1 |
| Santos, AA | 1 |
| Afonso, MB | 1 |
| Ramiro, RS | 1 |
| Pires, D | 1 |
| Pimentel, M | 1 |
| Castro, RE | 1 |
| Rodrigues, CMP | 1 |
| Pham, VT | 1 |
| Lacroix, C | 1 |
| Braegger, CP | 1 |
| Chassard, C | 1 |
| Hughes, ER | 1 |
| Furtado de Carvalho, T | 1 |
| Behrendt, CL | 1 |
| Hooper, LV | 1 |
| Berman, CM | 1 |
| Merritt, RJ | 1 |
| Iatsenko, I | 1 |
| Boquete, JP | 1 |
| Lemaitre, B | 1 |
| Machiels, K | 1 |
| Joossens, M | 1 |
| Sabino, J | 1 |
| De Preter, V | 1 |
| Arijs, I | 1 |
| Eeckhaut, V | 1 |
| Ballet, V | 1 |
| Claes, K | 1 |
| Van Immerseel, F | 1 |
| Verbeke, K | 1 |
| Ferrante, M | 1 |
| Verhaegen, J | 1 |
| Rutgeerts, P | 1 |
| Vermeire, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Tolerability and Risk of Adverse Events With a Probiotic Supplement: A Randomised and Placebo Controlled Study in Healthy Individuals[NCT03728868] | 50 participants (Actual) | Interventional | 2018-10-10 | Completed | |||
| PediCRaFT: Pediatric Crohn's Disease Fecal Microbiota Transplant Pilot Study[NCT03378167] | Phase 1 | 17 participants (Actual) | Interventional | 2018-12-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
21 other studies available for lactic acid and Disbacteriosis
| Article | Year |
|---|---|
Unraveling the Microbiome of Necrotizing Enterocolitis: Insights in Novel Microbial and Metabolomic Biomarkers.
Topics: Biomarkers; Clostridium; Clostridium perfringens; Dysbiosis; Enterocolitis, Necrotizing; Feces; Gast | 2021 |
Lactate-utilizing bacteria ameliorates DSS-induced colitis in mice.
Topics: Adult; Animals; Bacteria; Colitis; Dextran Sulfate; Dysbiosis; Fecal Microbiota Transplantation; Fec | 2022 |
Lactic Acid-Producing Probiotic
Topics: Animals; Caspase 1; Colitis, Ulcerative; Colon; Cytokines; Disease Models, Animal; Dysbiosis; Fatty | 2021 |
Elevated Levels of Circulating Biomarkers Related to Leaky Gut Syndrome and Bacterial Translocation Are Associated With Graves' Disease.
Topics: Autoantibodies; Bacterial Translocation; Biomarkers; China; Dysbiosis; Fatty Acid-Binding Proteins; | 2021 |
Vaginal microbiome dysbiosis in preterm birth.
Topics: Bacteria; Dysbiosis; Female; Humans; Infant, Newborn; Lactic Acid; Lactobacillus; Microbiota; Pregna | 2022 |
Colonocyte-derived lactate promotes E. coli fitness in the context of inflammation-associated gut microbiota dysbiosis.
Topics: Animals; Colitis; Dysbiosis; Enterobacteriaceae; Escherichia coli; Gastrointestinal Microbiome; Infl | 2022 |
Colonocyte-derived lactate promotes E. coli fitness in the context of inflammation-associated gut microbiota dysbiosis.
Topics: Animals; Colitis; Dysbiosis; Enterobacteriaceae; Escherichia coli; Gastrointestinal Microbiome; Infl | 2022 |
Colonocyte-derived lactate promotes E. coli fitness in the context of inflammation-associated gut microbiota dysbiosis.
Topics: Animals; Colitis; Dysbiosis; Enterobacteriaceae; Escherichia coli; Gastrointestinal Microbiome; Infl | 2022 |
Colonocyte-derived lactate promotes E. coli fitness in the context of inflammation-associated gut microbiota dysbiosis.
Topics: Animals; Colitis; Dysbiosis; Enterobacteriaceae; Escherichia coli; Gastrointestinal Microbiome; Infl | 2022 |
Colonocyte-derived lactate promotes E. coli fitness in the context of inflammation-associated gut microbiota dysbiosis.
Topics: Animals; Colitis; Dysbiosis; Enterobacteriaceae; Escherichia coli; Gastrointestinal Microbiome; Infl | 2022 |
Colonocyte-derived lactate promotes E. coli fitness in the context of inflammation-associated gut microbiota dysbiosis.
Topics: Animals; Colitis; Dysbiosis; Enterobacteriaceae; Escherichia coli; Gastrointestinal Microbiome; Infl | 2022 |
Colonocyte-derived lactate promotes E. coli fitness in the context of inflammation-associated gut microbiota dysbiosis.
Topics: Animals; Colitis; Dysbiosis; Enterobacteriaceae; Escherichia coli; Gastrointestinal Microbiome; Infl | 2022 |
Colonocyte-derived lactate promotes E. coli fitness in the context of inflammation-associated gut microbiota dysbiosis.
Topics: Animals; Colitis; Dysbiosis; Enterobacteriaceae; Escherichia coli; Gastrointestinal Microbiome; Infl | 2022 |
Colonocyte-derived lactate promotes E. coli fitness in the context of inflammation-associated gut microbiota dysbiosis.
Topics: Animals; Colitis; Dysbiosis; Enterobacteriaceae; Escherichia coli; Gastrointestinal Microbiome; Infl | 2022 |
Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions.
Topics: Candida; Cross-Sectional Studies; Dysbiosis; Female; Humans; Lactic Acid; Lung Neoplasms; Male | 2023 |
HiSorb sorptive extraction for determining salivary short chain fatty acids and hydroxy acids in heart failure patients.
Topics: Acetic Acid; Butyric Acid; Dysbiosis; Fatty Acids; Fatty Acids, Volatile; Gas Chromatography-Mass Sp | 2023 |
Precision modulation of dysbiotic adult microbiomes with a human-milk-derived synbiotic reshapes gut microbial composition and metabolites.
Topics: Adult; Dysbiosis; Gastrointestinal Microbiome; Humans; Infant; Lactic Acid; Microbiota; Milk, Human; | 2023 |
Effect of
Topics: Child; Cystic Fibrosis; Dysbiosis; Faecalibacterium; Fatty Acids; Humans; Lactic Acid; Lactobacillac | 2023 |
Gut microbial change after administration of
Topics: Animals; Disease Models, Animal; Dysbiosis; Gastrointestinal Microbiome; Lactic Acid; Lacticaseibaci | 2023 |
Gut Lactobacillus contribute to the progression of breast cancer by affecting the anti-tumor activities of immune cells in the TME of tumor-bearing mice.
Topics: Animals; Dysbiosis; Lactic Acid; Lactobacillus; Mice; Neoplasms; Streptomycin; Tumor Microenvironmen | 2023 |
Lactic acid enhances vaginal epithelial barrier integrity and ameliorates inflammatory effects of dysbiotic short chain fatty acids and HIV-1.
Topics: Dysbiosis; Fatty Acids, Volatile; Female; HIV Seropositivity; HIV-1; Humans; Lactic Acid; Vagina | 2023 |
Altered microbiota, fecal lactate, and fecal bile acids in dogs with gastrointestinal disease.
Topics: Animals; Bile Acids and Salts; Diarrhea; Dog Diseases; Dogs; Dysbiosis; Feces; Female; Gastrointesti | 2019 |
Altered gut microbiome composition in patients with Vogt-Koyanagi-Harada disease.
Topics: Adrenal Cortex Hormones; Adult; Animals; Biodiversity; Butyrates; Disease Models, Animal; DNA, Bacte | 2020 |
Host miRNA-21 promotes liver dysfunction by targeting small intestinal
Topics: Animals; Cholestasis; Dysbiosis; Female; Gastrointestinal Microbiome; Lactic Acid; Lactobacillus; Li | 2020 |
Lactate-utilizing community is associated with gut microbiota dysbiosis in colicky infants.
Topics: Bacteria; Chromatography, High Pressure Liquid; Colic; Dysbiosis; Feces; Female; Gastrointestinal Mi | 2017 |
Dysbiosis-Associated Change in Host Metabolism Generates Lactate to Support Salmonella Growth.
Topics: Animals; Anti-Bacterial Agents; Butyric Acid; Clostridium; Dysbiosis; Female; Fermentation; Gastroen | 2018 |
Stoned-A Syndrome of D-Lactic Acidosis and Urolithiasis.
Topics: Acidosis, Lactic; Adolescent; Dysbiosis; Feces; Female; Gastrointestinal Microbiome; Humans; Infant; | 2018 |
Microbiota-Derived Lactate Activates Production of Reactive Oxygen Species by the Intestinal NADPH Oxidase Nox and Shortens Drosophila Lifespan.
Topics: Animals; Carrier Proteins; Drosophila; Dysbiosis; Gene Expression; Intestinal Mucosa; L-Lactate Dehy | 2018 |
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Topics: Adult; Bacterial Load; Butyric Acid; Case-Control Studies; Colitis, Ulcerative; Denaturing Gradient | 2014 |
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Topics: Adult; Bacterial Load; Butyric Acid; Case-Control Studies; Colitis, Ulcerative; Denaturing Gradient | 2014 |
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Topics: Adult; Bacterial Load; Butyric Acid; Case-Control Studies; Colitis, Ulcerative; Denaturing Gradient | 2014 |
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Topics: Adult; Bacterial Load; Butyric Acid; Case-Control Studies; Colitis, Ulcerative; Denaturing Gradient | 2014 |